Fig 1 - by C. Vijay Reena Durai (14498259)

Subjects:

Binocular summation ratio. by C. Vijay Reena Durai (14498259)

Subjects:

Two Microsoft excel spreadsheets containing the raw data of the study have been added as supporting information. by C. Vijay Reena Durai (14498259)

Subjects:

Representation of better of the two eyes’ monocular FMTs and binocular FMTs. by C. Vijay Reena Durai (14498259)

Subjects:

Representation of better of the two eyes’ monocular FMTs and binocular FMTs. by C. Vijay Reena Durai (14498259)

Subjects:

Maintenance of a single Zeb2 wt allele rescues PB cytopenia and severe differentiation defects in Zeb1/2 DKO HSPCs. by Jueqiong Wang (11467505)

Cytosolic mitochondrial DNA release upon MeV and MeV-ΔV infection in culture and in mice. by Pierre Khalfi (7868252)

Effects of vidarabine, V2E, V3E and V5E on AC activity in the heart of WT and AC5KO mice. by Kenji Suita (750993)

“…<p>(A) Vidarabine (Vida), V2E, V3E and V5E similarly and significantly decreased ISO (50 µmol/L)-stimulated AC activity in the WT heart in a dose-dependent manner. …”

<i>Gnas</i> deletion in hypothalamic <i>Opn5</i> neurons. by Kevin D. Gaitonde (15411707)

Subjects:

Comparison of the decrease of CFU in CSF and blood between treatment groups within the first 6 h after treatment. by Luca G. Valente (12463057)

Fig 5 - by Héctor Raúl Olivares-Sánchez (13014866)

Annual treatment frequencies in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

“…Mean outpatient visits in the recurrence group decreased from 13.6 ± 3.0 to 11.9 ± 5.0, 8.1 ± 3.9, and 7.8 ± 3.2 at 1, 2, and 3 years postoperatively, respectively (Kruskal-Wallis test, p < 0.001). …”

MBIC50 and MBEC50 values (µg/mL) of synthesized 1,2,3,5-tetrazine derivatives against bacteria pathogen strains. by Jean Paul Dzoyem (6424445)

Subjects:

Annual number of outpatient visits in all eyes. by Yasuyuki Sotani (20114144)

“…<p>Mean visit frequency (mean ± standard deviation) significantly decreased from 11.5 ± 4.3 preoperatively to 8.8 ± 4.1, 5.0 ± 3.4, and 4.4 ± 3.2 visits in the first, second, and third postoperative years, respectively (Kruskal–Wallis test, P < 0.001; Dunn’s test, **P < 0.01). …”

Annual treatment frequencies in all eyes. by Yasuyuki Sotani (20114144)

“…Outpatient visit frequency also significantly declined from 11.5 ± 4.3 visits in the year before surgery to 8.8 ± 4.1, 5.0 ± 3.4, and 4.4 ± 3.2 visits in the first, second, and third postoperative years, respectively (Kruskal-Wallis test, p < 0.001; <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0332941#pone.0332941.g004" target="_blank">Fig 4</a>).…”

Annual number of outpatient visits in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

“…<p>In the recurrence group, mean outpatient visits (± standard deviation) decreased from 13.6 ± 3.0 to 11.9 ± 5.0, 8.1 ± 3.9, and 7.8 ± 3.2 at 1, 2, and 3 years postoperatively, respectively (Kruskal-Wallis test, P < 0.001; Dunn’s test, **P < 0.01). …”

Mean frequency of the cultural trait <i>T</i> in the population when <i>T</i> decreases fertility. by Laurel Fogarty (143721)

Difference in mean Capability scores by age (≥55 vs. <55 years) among people with TB. by Kevin Guzman (16474985)

Difference in mean Motivation scores by age (≥55 vs. <55 years) among people with TB. by Kevin Guzman (16474985)

Difference in mean Opportunity scores by age (≥55 vs. <55 years) among people with TB. by Kevin Guzman (16474985)